Thermo Fisher (TMO) witnesses solid growth globally. Foreign exchange headwinds remain.
The multi-year, comprehensive laboratory deal to help LabCorp (LH) provide high-quality, high-value and standardized laboratory diagnostics for Appalachian Regional Healthcare.
Thermo Fisher Scientific (TMO) forges ahead with initiatives to strengthen its hold in the high-potential human identification market.
How the Medical Industry is Improving Life for Japan’s Aging Population - SPONSOR CONTENT FROM THE GOVERNMENT OF JAPAN
Everyone in Japan knows its citizenry is getting older at a faster rate than that of any other nation. But for outsiders, the most striking insight may be that the Japanese want to face aging well. In fact, by government edict, the goal is to direct policy, health care, and even citizens themselves toward longer, healthier, more enriching lives. The resulting lessons will be critical to life science companies worldwide as the aging trend prevalent in Japan expands to other nations. These companies are using Japan to deepen their understanding of the business opportunities in health care, medical equipment, and related services resulting from the innate human desire for happiness at any age. Read More from the Government of Japan How Japan is Creating New Opportunities for Life Sciences Companies How Japan is Creating New Opportunities in the Field of Regenerative Medicine Why the Pharmaceutical Industry Is Booming in Japan Japan already enjoys the world’s second-biggest market in medical devices. For example, the nation leads the world in MRI machines per capita. By country, Japan had 9.1 percent of the 2014 global medical device market—behind the U.S. and ahead of Germany. Meanwhile, Japan’s market is expected to continue to grow as the nation’s population continues to age and need medical equipment. Philips, the Dutch electronics and health care corporation, is among the foreign companies attracted to Japan’s market. Philips is teaming with Japanese doctors to join a “hospital to home” solution that emphasizes getting people out of expensive care facilities and back home, where they want to be. Philips’s range of ventilation, sleep therapy, and monitoring equipment is an ideal part of such a plan, as Danny Risberg, general manager of Philips Healthcare in Japan, disclosed in a recent presentation. Risberg pointed out that Japan’s average hospital stay is three times longer than the average in the U.S. or the Netherlands, so “in-hospital treatment is not sustainable.” Philips also is part of the trend toward corporate-university collaboration, with relationships with the universities of Nagasaki, Kobe, and Showa. One project is a remote intensive-care patient management program. The hospital-to-home movement exemplifies Japanese government programs to help its aging populace. This also includes innovative systems for patient-requested care, promotion of self-medication, cloud-based record availability, and remote monitoring of patients in their homes. Japan also promotes new markets for accessible technologies and devices that patients can use to treat themselves without expensive facilities or expert assistance. It’s all part of a health care and medical strategy adopted in 2014 by the government—a policy initiative based on the concept that Japanese society will benefit from advances in both health care and the economic growth needed to support it. The issue is complex, and Japanese and non-Japanese companies are rising to the challenge. Robotics: Japan realizes it will be short hundreds of thousands of people needed to provide traditional health care as its populace ages and declines in numbers. Part of the solution is to promote women’s participation in the workplace and increase the use of foreign workers—a classic way to fill health care jobs. But “carebots” and other robotic helpers also are being developed, not only for aging patients but also for caregivers themselves. Studies show that as many as 70 percent of health care workers in Japan suffer from back problems because they so often lift or support patients. Robotic aids being developed by companies such as Cyberdyne and Panasonic involve exoskeletons to help caregivers handle patients without strain. Treatment: The increasing medical needs of an aging populace are creating interest among more and more companies. IBA, a Belgian firm, recently took advantage of Japanese government support to open a subsidiary in Tokyo to promote its radiation therapy systems. And Medtronic, the medical device company, recently earned Japanese regulatory approval for a miniaturized pacemaker. Other companies realize that Japan’s medical devices will need repair and replacement over time, creating another market opportunity. Non-Japanese companies involved in or expanding into the medical device market in Japan include Karl Storz and Siemens of Germany, plus Thermo Fisher Scientific and Intuitive Surgical from the United States. These and other trends are combining with specific law changes that speed regulatory approval in Japan. Conditional early approval expanded to cover innovative medical devices in July 2017. Now, the Japanese National Diet, Japan’s bicameral legislature, is considering more benefits for the pharmaceutical and medical device industries that match those given to the booming regenerative medicine fields, according to Colin Lee Novick, managing director of the CJ Partners biotech consulting firm in Tokyo. If the Diet acts, Novick adds, “I would say that the red carpet has been rolled out across the board” in life sciences for all of Japan. Find more at Japan.go.jp/abenomics.
Illumina (ILMN) successfully broadens base by enriching its portfolio of sequencing products and building strategic partnerships with therapeutic and diagnostic service providers.
Illumina's (ILMN) recently-signed partnership to distribute Thermo Fisher's Ion AmpliSeq technology is encouraging.
Российские ученые хотят коммерциализовать новый латеральный проточный иммуноанализ для диагностики инфаркта и сепсиса
Изобретатели получили патент на эту технологию в России, но не добились для нее защиты где-нибудь еще. Патент RU2510510C1, «Тест-система для полуколичественного иммунохроматографического анализа», описывает пластиковую подложку с поверхностью, покрытой аналитической мембраной, на которой «сформировано от 2 до 10 дискретных параллельных тестовых линий путем предварительного нанесения на мембрану растворов вторых специфических моноклональных антител против определяемого соединения, причем концентрация антител последовательно возрастает от линии к линии».
Today, Speaker Ryan discussed how each day, more Americans are benefiting from the new tax law: “Yesterday, the president was in Ohio to talk about the good news still rolling in on tax reform. Just over this past week, companies like UPS, Lowe’s, Cigna, Thermo Fisher Scientific, and Best Buy announced bonuses, they announced pay raises, they announced additional benefits for their employees. “Right now, thanks to tax reform, companies have announced more than $2.5 billion in bonuses and $179.5 billion in new investments in this country already. More than 4.3 million workers have benefited. And of course, as a result of tax reform, the average family of four will save more than $2,000 this year. Tax reform is working. “And there have been significant economic gains. U.S. employers added 200,000 jobs in January, with wages growing at the biggest rate in eight years. Unemployment is at a 17-year low, and tax cuts are only going to help raise wages and create more good jobs. Speaker Ryan also discussed the Democrats’ ongoing strategy to hold government funding hostage: “Finally, as was mentioned by the majority leader and others, we are voting on yet another continuing resolution this week. I will remind you that the only reason we do not have a full budget agreement is because Democrats continue to hold funding for our government hostage on an unrelated issue. They must stop using our troops as pawns in a game of politics, and that’s why the House will send the Senate a bill to fully fund our military for this year while we keep working toward a budget agreement. “I urge the Senate Democrats to stop their filibuster and provide our men and women in uniform the resources that they need, they support that they need. Quite literally, the safety of our service members and the security of our country is at stake.”
Yesterday, President Trump visited Sheffer Corp. in Blue Ash, Ohio to tout the early benefits of tax reform sweeping the country. Sheffer, a hydraulic and pneumatic cylinders manufacturer, is home to 126 employees—all of whom received $1,000 bonuses following the enactment of the Tax Cuts and Jobs Act. As the company’s President and CEO, Jeff Norris, said before the speech, “Some people have said that’s ‘crumbs,’ but for the Sheffer people, we consider that fine dining.” The president’s visit could not have come at a better time. Just last week, UPS, Lowe’s, Cigna, Thermo Fisher Scientific, and Hostess announced new rewards for their employees' due at least in part to tax reform. Yesterday, Anthem announced it will make $1,000 contributions to their employees 401(k) accounts. And this month, as new withholding tables take effect, 90 percent of Americans will see more take-home pay in their paychecks thanks to the Tax Cuts and Jobs Act. The average family of four will save more than $2,000 this year alone. Where Democrats see “crumbs,” Americans are seeing more money in their pockets as a result of the new law. From bonuses to wage increases and higher 401(k) contributions, tax reform is making life easier for hardworking people and families nationwide. And that’s what this is really all about.
Thermo Fisher's (TMO) acquisition of FEI Company already adds capabilities to its analytical instruments portfolio. Also, solid cash in hand enables the company to yield fat returns to investors.
In the last 24 hours, there has been more good news spurred on by the Tax Cuts and Jobs Act, passed by Congress and signed into law right before Christmas. UPS: Today, UPS announced more than $12 billion in investments to expand the company’s Smart Logistics Network, significantly increase pension funding, and position the company to further enhance shareholder value. Lowe's: Also today, Lowe's announced it would provide bonuses for more than 260,000 hourly employees and expand its benefits package. Cigna: Yesterday, Cigna announced it would raise their minimum wage, provide $15 million in salary raises, add $30 million to the 401k program, and make additional investments to its foundation. Thermo Fisher Scientific: And finally, Thermo Fisher Scientific announced yesterday it will make investments totaling $50 million in its people and the U.S., including $34 million for a $500 bonus for its 68,000 employees and $16 million to invest in R&D and STEM programs. All of these companies credited the new tax reform law for these actions that will benefit their employees and the United States. Yesterday, a new Monmouth poll came out showing the favorability of the tax reform law is way up. In December, 26% of Americans approved of the bill and 47% disapproved. But now 44% approve and 44% disapprove. That’s a swing of 21 points. Americans are really starting to get it. That’s in large part because the benefits of tax reform are being heard, seen, and felt by Americans around the country. The poll also dived into those Americans who believed their taxes would go up: “Perhaps more importantly, fewer Americans (36%) believe that their own federal taxes will go up under the plan than felt the same when the bill was in its final legislative stages last month (50%).” The reality is even better. When the Treasury Department instructed the IRS to activate the new withholding tables, it estimated that 90 percent of wage-earners will experience an increase in their take-home pay. So more good news is coming for Americans across the country.
Today, Thermo Fisher Scientific announced that it will invest an additional $50 million in the United States following enactment of the Tax Cuts and Jobs Act. Read the full press release here or below: Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will make additional investments totaling $50 million as a result of the benefit of recently enacted Federal tax reform legislation in the U.S. This investment includes: $34 million for a one-time bonus of $500 to be paid to each of the company's approximately 68,000 eligible non-executive employees globally; $16 million to accelerate key breakthrough R&D programs and also to increase the impact of the company's sustainability initiatives and philanthropic activities in support of STEM (Science, Technology, Engineering and Math) education. "Thermo Fisher will benefit from tax reform, so we chose to use this unique opportunity to recognize the commitment of our colleagues who work hard every day to fulfill our Mission – to enable our customers to make the world healthier, cleaner and safer," said Marc N. Casper, president and chief executive officer, Thermo Fisher Scientific. "We also plan to use the benefit to fuel important programs that will strengthen our ability to serve our customers and the communities where we live and work."
Thermo Fisher (TMO) registers a solid international performance in Q4 with strong year-over-year growth in the Asia-Pacific and the emerging markets of China, South Korea and the Middle East.
Thermo Fisher (TMO) rides high on strength in all segments in Q4.